DK316176A - Histamin h2-antagonister - Google Patents

Histamin h2-antagonister

Info

Publication number
DK316176A
DK316176A DK316176A DK316176A DK316176A DK 316176 A DK316176 A DK 316176A DK 316176 A DK316176 A DK 316176A DK 316176 A DK316176 A DK 316176A DK 316176 A DK316176 A DK 316176A
Authority
DK
Denmark
Prior art keywords
histamin
antagonists
Prior art date
Application number
DK316176A
Other languages
Danish (da)
English (en)
Inventor
G J Durant
C R Ganellin
G S Sach
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of DK316176A publication Critical patent/DK316176A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/68One oxygen atom attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK316176A 1975-07-31 1976-07-13 Histamin h2-antagonister DK316176A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB31970/75A GB1564502A (en) 1975-07-31 1975-07-31 Guanidines thioureas and 1,1-diamino-2-nitroethylene derivatives

Publications (1)

Publication Number Publication Date
DK316176A true DK316176A (da) 1977-02-01

Family

ID=10331105

Family Applications (1)

Application Number Title Priority Date Filing Date
DK316176A DK316176A (da) 1975-07-31 1976-07-13 Histamin h2-antagonister

Country Status (31)

Country Link
US (4) US4083983A (fi)
JP (2) JPS5219671A (fi)
AR (1) AR213736A1 (fi)
AT (1) AT356132B (fi)
AU (1) AU502752B2 (fi)
BE (1) BE844504A (fi)
BG (1) BG27368A3 (fi)
CA (1) CA1068711A (fi)
CH (1) CH624938A5 (fi)
CS (1) CS189018B2 (fi)
DD (1) DD125204A5 (fi)
DE (1) DE2634433A1 (fi)
DK (1) DK316176A (fi)
ES (1) ES450310A1 (fi)
FI (1) FI762193A (fi)
FR (1) FR2319343A1 (fi)
GB (1) GB1564502A (fi)
GR (1) GR60810B (fi)
HU (1) HU173778B (fi)
IE (1) IE43508B1 (fi)
IL (1) IL50005A (fi)
LU (1) LU75507A1 (fi)
NL (1) NL7608496A (fi)
NO (1) NO762661L (fi)
PH (1) PH14555A (fi)
PL (1) PL103684B1 (fi)
PT (1) PT65348B (fi)
SE (1) SE7608477L (fi)
SU (1) SU692558A3 (fi)
ZA (1) ZA764082B (fi)
ZM (1) ZM9876A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4928863A (fi) * 1972-07-13 1974-03-14
JPS5078968U (fi) * 1973-11-20 1975-07-08
ZA774220B (en) * 1976-07-28 1978-06-28 Smith Kline French Lab Pharmacologically active compounds
US4165378A (en) 1977-04-20 1979-08-21 Ici Americas Inc. Guanidine derivatives of imidazoles and thiazoles
ZA782129B (en) 1977-04-20 1979-03-28 Ici Ltd Hertocyclic derivatives
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them
US4282363A (en) * 1978-11-24 1981-08-04 Bristol-Myers Company 1-Nitro-2-(2-alkynylamino)-2-[(2-pyridylmethylthio)-ethylamino]ethylene derivatives
US4250316A (en) * 1978-11-24 1981-02-10 Bristol-Myers Company Pyridyl guanidine anti-ulcer agents
US4287346A (en) * 1979-02-16 1981-09-01 Eisai Co., Ltd. Cyanoguanidine derivatives
PT74865B (en) * 1981-05-27 1983-12-07 Smithkline Beckman Corp Process of preparing a 2-(pyridylbutylamino)-pyrimidone and of its pharmaceutically acceptable salts
SE8204879D0 (sv) * 1982-08-26 1982-08-26 Haessle Ab Novel chemical intermediates
DE3232462A1 (de) * 1982-09-01 1984-03-01 Bayer Ag, 5090 Leverkusen 2-nitro-1,1-ethendiamine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPH0828166B2 (ja) * 1985-01-16 1996-03-21 松下電器産業株式会社 サ−モスタツト
AU660132B2 (en) * 1992-12-21 1995-06-08 Bayer Aktiengesellschaft Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridine
US5380734A (en) * 1993-04-15 1995-01-10 American Home Products Corporation N-cyanoamidine derivatives as anti-influenza agents
CA3104669A1 (en) 2018-06-29 2020-01-02 410 Medical, Inc. Systems, apparatus, and methods for filtering air from a fluid line
EP4196793A1 (en) 2020-08-11 2023-06-21 Université de Strasbourg H2 blockers targeting liver macrophages for the prevention and treatment of liver disease and cancer

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3968216A (en) * 1969-10-29 1976-07-06 Smith Kline & French Laboratories Limited Method of inhibiting histamine activity with guanidine compounds
US3908014A (en) * 1970-06-25 1975-09-23 Smith Kline French Lab Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3808336A (en) 1970-06-25 1974-04-30 Smithkline Corp Pharmaceutical compositions and methods of inhibiting histamine activity with thiourea derivatives
US3905984A (en) * 1971-03-09 1975-09-16 Smith Kline French Lab Pyridyl substituted thioalkyl-and oxyalkyl-thioureas and ureas
GB1338169A (en) * 1971-03-09 1973-11-21 Smith Kline French Lab Ureas thioureas and guanidines
GB1397436A (en) * 1972-09-05 1975-06-11 Smith Kline French Lab Heterocyclic n-cyanoguinidines
GB1421792A (en) * 1973-05-17 1976-01-21 Smith Kline French Lab Heterocyclic substituted-1, 1-diamino-ethylene derivatives methods for their preparation and compositions containing them
US4002759A (en) * 1973-05-17 1977-01-11 Smith Kline & French Laboratories Limited Pyridylbutylamino ethylene compounds
US4025527A (en) * 1973-07-13 1977-05-24 Smith Kline & French Laboratories Limited Certain thiazoles and oxazoles
GB1497260A (en) * 1974-06-28 1978-01-05 Smith Kline French Lab Guanidine derivatives

Also Published As

Publication number Publication date
DE2634433A1 (de) 1977-02-03
SU692558A3 (ru) 1979-10-15
US4083983A (en) 1978-04-11
GR60810B (en) 1978-08-30
CS189018B2 (en) 1979-03-30
US4264608A (en) 1981-04-28
PL103684B1 (pl) 1979-07-31
PT65348A (en) 1976-08-01
IL50005A (en) 1981-06-29
AR213736A1 (es) 1979-03-15
GB1564502A (en) 1980-04-10
US4426526A (en) 1984-01-17
ZA764082B (en) 1977-06-29
NO762661L (fi) 1977-02-01
FR2319343A1 (fr) 1977-02-25
IL50005A0 (en) 1976-09-30
IE43508B1 (en) 1981-03-11
FR2319343B1 (fi) 1978-11-17
AT356132B (de) 1980-04-10
ZM9876A1 (en) 1977-09-21
IE43508L (en) 1977-01-31
ES450310A1 (es) 1977-12-01
US4215126A (en) 1980-07-29
JPS617423B2 (fi) 1986-03-06
SE7608477L (sv) 1977-02-01
HU173778B (hu) 1979-08-28
AU502752B2 (en) 1979-08-09
CA1068711A (en) 1979-12-25
PH14555A (en) 1981-09-24
AU1645376A (en) 1978-02-02
NL7608496A (nl) 1977-02-02
CH624938A5 (fi) 1981-08-31
FI762193A (fi) 1977-02-01
DD125204A5 (fi) 1977-04-06
JPS60243069A (ja) 1985-12-03
PT65348B (en) 1978-01-06
BG27368A3 (en) 1979-10-12
LU75507A1 (fi) 1977-03-03
BE844504A (fr) 1977-01-24
JPS5219671A (en) 1977-02-15
ATA552576A (de) 1979-09-15

Similar Documents

Publication Publication Date Title
DK146197C (da) Brusehoved
SE7605471L (sv) Duschhuvud
DK143966C (da) Tandboerste
DK316176A (da) Histamin h2-antagonister
AT350119B (de) Zeitbasis-ausgleichkreis
DK587076A (da) Fremgangsmade til fremstilling af histamin h2-antagonister
DK147134C (da) Forbindelsesorgan
IT1054049B (it) Elettrolizzatore
DK316376A (da) Histamin h2-antagonister
FR2330926A1 (fr) Elements d'etancheite
DK316076A (da) Histamin h2-antagonister
FR2327668A1 (fr) Vibreur
DK517476A (da) Histamin h2-antagonister
SE7613935L (sv) Substituerad triazoleter
FI65878B (fi) Vertikal avboejningskrets
FR2299028A1 (fr) Nouvea
FR2307888A1 (fr) Electrolyseur
DK331977A (da) Histamin h2-anatagonister
DK331877A (da) Histamin h2-antagonister
FR2301243A1 (fr) Nouve
BE840864A (fr) Agents thermo-sensibilisateurs
FR2323377A1 (fr) Derives benzyloxyalkyles
ATA745575A (de) Zahnbuerste
JPS51103409A (ja) Shingoshorikairo
JPS5185738A (ja) Shingobunbaiki